Hairy Cell Leukemia: An Elusive But Treatable Disease

Hairy Cell Leukemia: An Elusive But Treatable Disease Sam O. Wanko, Carlos DeCastro Oncologist 2006; 11: 780-789 Author Information and Disclosures Target Audience: Physicians who wish to advance their current knowledge of clinical cancer medicine in the community oncology setting. Method of Physician Participation: Read course materials, complete course quiz and evaluation form. Learning Objectives After completing this course, the reader should be able to: Describe what is known about the biology and pathogenesis of HCL. Discuss the clinical presentation and differential diagnosis of HCL. Identify important diagnostic markers for HCL. Discuss treatment options and response and adverse effects to therapy for HCL. The NIH/FAES designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CME Activity Information Accreditation CME Instructions For Credit Privacy Statement Hardware/Software Requirements Release Date: Jul. 31, 2006 Most Recent Review: Jul. 31, 2006* Most Recent Update: Jul. 31, 2006 Date Credit Expires: Jul. 31, 2008 Time to Complete: 1 hour Medium: Internet Online *Click here to learn more about our review process.